Neuroscience has been identified as a priority around the globe through initiatives in the United States, Europe, Asia, and the Middle East. In an era of flat or declining budgets for biomedical research, what impact will these large-scale projects have throughout the field? What will be the role of private funding for these and other initiatives? Hear a panel of experts discuss how these projects and the way they are funded will affect individual research projects, primary investigators, universities, businesses, and science as a whole.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you donâ€™t lose access.
Already a member? Login now
Not a member? Become a member now